We speculate that the discordance in PD-L1 TPS between 22C3 and E1L3N assays was due to the inherent spatial heterogeneity of tumors that could result in the discrepancy in tumor content of the microsections used for these two assays. This evidence concerns the gene CD274 and neoplasm.